Country: United Kingdom
Bahasa: Inggeris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cyanocobalamin
A A H Pharmaceuticals Ltd
B03BA01
Cyanocobalamin
50microgram
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010200; GTIN: 5025903085041
CYANOCOBALAMIN 50 MICROGRAMS TABLETS Vitamin B 12 50 TABLETS P Each film coated tablet contains 50 micrograms cyanocobalamin. Also contains lactose. See leaflet for further information. To be taken by mouth. Use as directed by your doctor. DOSAGE: Adults and Elderly - Usual dose is 1 to 3 tablets or more, daily between meals. Children: Usual dose is 1 tablet. Keep out of the sight and reach of children. Do not store above 25°C. Store in the original container in order to protect from light. Keep the container tightly closed. Marketing Authorisation Holder: Mercury Pharma Group Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK PL 10972/0028 LL-117965-01 50 MICROGRAMS CYANOCOBALAMIN 50 MICROGRAMS TABLETS Vitamin B 12 50 TABLETS P Each film coated tablet contains 50 micrograms cyanocobalamin. Also contains lactose. See leaflet for further information. To be taken by mouth. Use as directed by your doctor. DOSAGE: Adults and Elderly - Usual dose is 1 to 3 tablets or more, daily between meals. Children: Usual dose is 1 tablet. Keep out of the sight and reach of children. Do not store above 25°C. Store in the original container in order to protect from light. Keep the container tightly closed. Marketing Authorisation Holder: Mercury Pharma Group Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK PL 10972/0028 LL-117965-01 11001620 50 MICROGRAMS B.No : Exp : PREGNANCY, BREAST FEEDING AND FERTILITY If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. As with all drugs Cyanocobalamin Tablets should only be given in pregnancy and when breast feeding if absolutely necessary. CYANOCOBALAMIN TABLETS CONTAINS LACTOSE This medicine also contains lactose (which is a sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. 3. HOW TO TAKE CYANOCOBALAMIN TABLETS Always take this medicine exactly as de Baca dokumen lengkap
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT _ _ Cytacon 50micrograms Tablets Cyanocobalamin 50micrograms Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 50 micrograms Cyanocobalamin BP. Excipient(s) with known effect For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Recommended Clinical Indications: Treatment of nutritional Vitamin B 12 deficiency. Treatment of vitamin B 12 deficiency following partial gastrectomy. Treatment of tropical sprue, alone or with folic acid. Treatment of pernicious anaemia when parenteral administration is not possible or not advised. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Elderly: The normal dose for adults is appropriate for the elderly. Adults: One to three tablets (50 to 150 micrograms) or more daily at the discretion of the physician. In pernicious anaemia intramuscular therapy is preferable for initial correction of vitamin B12 deficiency. However, if necessary, the oral route may be used to follow this, in which case at least 300 micrograms should be given daily Paediatric population: One tablet (50 micrograms) daily at the discretion of the physician. When possible, This medicine doses should be taken between meals. Method of administration: Oral. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Hypersensitivity to the product or any of the excipients. 4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE For pernicious anaemia, an adequate dose must be used and the blood picture must be examined regularly at least every three months for 18 months until stabilised, and then annually. Indiscriminate administration of this medicine may mask precise diagnosis. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine. 4.5 INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF Baca dokumen lengkap